AGP Executive Report
Last update: 9 hours agoCannabis Use Disorder Watch: A new JAMA Psychiatry analysis of 186,823 U.S. adults (2021–2024) finds cannabis use disorder is rising alongside higher potency and legalization, with prevalence patterns varying by age and compared against alcohol use disorder. Hemp Ban Delayed: In the U.S., a stopgap funding bill signed by President Trump pushes back most federal restrictions on certain hemp-derived cannabinoid products to Dec. 11, buying time for new rules. Policy & Access (Ghana): Ghana’s NACOC is teaming with CSIR to advance low-THC (≤0.3%) cannabis research and cultivation, with tighter oversight, lab testing, and traceability. Treatment Trends: A federal report says fewer people are being admitted to substance abuse treatment primarily for cannabis use (down about 20% from 2020–2024), while alcohol-related admissions rise. Cybersecurity Risk: A Russian forum listing claims access to 153M+ U.S./Canadian driver’s licenses, including medical cards tied to legal marijuana purchases, prompting FBI inquiry. Public Safety: Texas and California are ramping up Labor Day impaired-driving enforcement, explicitly warning that THC/cannabis can impair driving. Kentucky Expansion: Kentucky opened its 24th licensed medical marijuana dispensary, bringing the state closer to full retail coverage.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.